Paris – At least 30 to 40 percent of people who are HIV positive in sub-Saharan Africa are dying due to late diagnosis and treatment failure, Medecins Sans Frontiers has said.

A package of low-cost drugs designed to prevent deadly infections among people who are starting HIV treatment late could save 10,000 lives a year across sub-Saharan Africa, scientists believe.

A nine-year-old infected with HIV at birth has spent most of their life without needing any treatment, say doctors in South Africa.

WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries. The Organization warns that this growing threat could undermine global progress in treating and preventing HIV infection if early and effective action is not taken.

Dar es Salaam — The government plans to include a new generic version of the anti-retroviral drug Dolutegravir (DTG) in the national HIV/Aids treatment protocols.

Kenya has become the first African country to introduce the generic version of the new first-line drug Dolutegravir (DTG) for people living with HIV.

Nigeria introduced efforts towards preventing mother-to-child transmission of HIV, several years ago, but despite significant progress in reducing new HIV infections among children, the country is

WHILE it is a universally accepted norm that a healthy nation is a wealthy one, the scourge of HIV/AIDS on the contrary has impacted negatively on many economies around the globe.

No fewer than 1.7million women and 380,00 children under age 15, are currently living with HIV/AIDS in Nigeria according to the 2015 data by the National AIDS & STIs Control Program (NASCP) of

Zimbabwe is one of the countries battling to contain fresh HIV infections among youths, where girls in the 15 to 19 year age group account for seven out of every 10 new infections.

Pages